Antifungal Agent Market
Global Antifungal Agent Market Size, Share & Trends Analysis Report By Drug Class (Polyene, Echinocandins, Allylamines, and Azole), By Dosage Type (Powder, Ointment and Drugs), and By Route Of Administration (Parental, Topical and Oral) Forecast 2022-2028
The global antifungal agent market is anticipated to grow at a significant CAGR of 3.1% during the forecast period. Growing effective treatment associated with fungal infections is acting as an important factor driving the growth of the market. Common fungal infections, such as ringworm and fungal nail infections, normally affect the body's exterior surface, whereas fungal diseases affect the body's tissues or internal organs, such as the lungs and brain. Individuals with a weakened immune system, such as those living with HIV/AIDS, are more likely to contract the fungus require effective treatment. Furthermore, chemotherapy patients are vulnerable to invasive fungal infections. Antifungal medications work against fungal infections by either killing or suppressing the growth of the fungus.
Impact of COVID-19 Pandemic on Global Antifungal Agent Market
The COVID-19 pandemic had impacted the global economy due to a slowdown in the manufacturing of various industries. The global antifungal medicines market has also been hampered by the supply chain slow down. However, the COVID-19 had also impacted the market growth due to patients with a weakened immune system are at a higher risk of contracting a life-threatening fungal infection and developing respiratory problems. For instance, invasive aspergillosis is caused by aspergillus spores that are commonly found in the air we breathe. As a result, there may be an increase in respiratory illnesses, which would support the market development by providing effective treatment. Additionally, antifungal drugs were also in higher demand as the number of cases of black fungus, white fungus, and pink fungus had increased.
Segmental Outlook
The global antifungal agent market is segmented based on the drug class, dosage type, and route of administration. Based on the drug class type, the market is segmented into polyene, echinocandins, allylamines, and azole. Based on the dosage type, the market is sub-segmented into powder, ointment, and drugs. Based on the route of administration, the market is sub-segmented into parental, topical, and oral.
Global Antifungal Agent Market Share by Drug Class, 2021 (%)
The Azole Segment is Anticipated to Hold a Prominent Share in the Global Antifungal Agent Market
Azoles are synthetic and semi-synthetic chemicals that are commonly used to treat fungal infections, both superficial and invasive. Thrush, yeast infection, candidiasis, aspergillosis, tinea versicolor, athlete's foot, jock itch, ringworm, fungal infections, systemic mycosis, and seborrheic dermatitis are all treated with these medications. There are fewer side effects, fewer major drug interactions, and better absorption and distribution qualities in these pharmaceuticals. Azole's dominance over other categories can be attributed to the aforementioned advantages. As a result, azoles are currently the most commonly used and researched antifungal agent class. Different formulations of the medications are offered such as capsule, cream, sterile IV solution, lotion, vaginal cream, and tablet.
Regional Outlooks
The global antifungal agent market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).
Global Antifungal Agent Market Growth, by Region 2022-2028
The Asia-Pacific Region is Estimated to Hold the Major Share in the Global Antifungal Agent Market
Asia-Pacific is the market's fastest-growing region. Improved healthcare infrastructure, rising prevalence of black fungus and other fungi in countries such as India, and more medical tourism in the region are all contributing reasons towards the market. As a result, businesses are concentrating their efforts in the region by increasing R&D spending and commercializing branded drugs at a cheaper cost. Additionally, partnerships and collaborations, product launches, and mergers and acquisitions are a few of the key methods used by market participants to obtain a competitive advantage over their rivals.
Market Players Outlook
The major companies serving the global antifungal agent market include Gilead Sciences, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. Market players are indulged in conducting clinical trials for the development of antifungal drugs, which is expected to increase the growth of the global antifungal drugs market over the forecast period. For instance, Pfizer, Inc. is conducting clinical trials for determining the effectiveness, safety, and treatment patterns of isavuconazole sulfate in the treatment of patients suffering from mucormycosis or invasive aspergillosis. The trial is currently in Phase II and is expected to be completed by May 26, 2022.
In December 2021, Sun Pharma's anti-fungal injection receives FDA approval. The shot will be used to treat fungal infections of the spinal cord and brain lining, along with parasite sickness that affects the spleen, liver, and bone marrow in some people.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global antifungal agent market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Antifungal Agent Market
• Recovery Scenario of Global Antifungal Agent Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Gilead Sciences, Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Merck & Co., Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Novartis AG
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Pfizer Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Sanofi
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Antifungal Agents Market By Drug Class
4.1.1. Polyene
4.1.2. Echinocandins
4.1.3. Allylamines
4.1.4. Azole
4.2. Global Antifungal Agents Market By Dosage Type
4.2.1. Powder
4.2.2. Ointment
4.2.3. Drugs
4.3. Global Antifungal Agents Market By Route of Administration
4.3.1. Parenteral
4.3.2. Topical
4.3.3. Oral
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Astellas Pharma Inc.
6.3. Basilea Pharmaceutica Ltd.
6.4. Bayer Healthcare LLC
6.5. Bristol-Myers Squibb Co.
6.6. Cadila Healthcare Ltd.
6.7. Cosmo Pharmaceuticals N.V.
6.8. Dr. Reddy’s Laboratories Ltd.
6.9. Enzon Pharmaceuticals, Inc
6.10. Janssen Pharmaceutica NV
6.11. Mayne Pharma Group Ltd.
6.12. SCYNEXIS, Inc.
6.13. Sumitomo Dainippon Pharma Co., Ltd.
6.14. Sun Pharmaceutical Industries Ltd.
6.15. Teva Pharmaceutical Industries Ltd.
6.16. Viatris Inc.
1. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
2. GLOBAL POLYENE ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ALLYLAMINES ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL AZOLE ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
7. GLOBAL POWDER ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OINTMENT ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL DRUGS ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
11. GLOBAL ANTIFUNGAL AGENT MARKET BY PARENTERAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL ANTIFUNGAL AGENT MARKET BY TOPICAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL ANTIFUNGAL AGENT MARKET BY ORAL RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
17. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
18. NORTH AMERICAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
19. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
21. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
22. EUROPEAN ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
23. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
27. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
29. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD ANTIFUNGAL AGENT MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENT MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ANTIFUNGAL AGENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ANTIFUNGAL AGENT MARKET, 2022-2028 (%)
4. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
5. GLOBAL POLYENE ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ECHINOCANDINS ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL ALLYLAMINES ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL AZOLE ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY DOSAGE TYPE, 2021 VS 2028 (%)
10. GLOBAL POWDER ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL OINTMENT ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL DRUGS ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY ROUTE OF ADMINISTRATION, 2021 VS 2028 (%)
14. GLOBAL ANTIFUNGAL AGENT BY PARENTERAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL ANTIFUNGAL AGENT BY TOPICAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL ANTIFUNGAL AGENT BY ORAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL ANTIFUNGAL AGENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. US ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
19. CANADA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
20. UK ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
21. FRANCE ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
22. GERMANY ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
23. ITALY ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
24. SPAIN ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF EUROPE ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
26. INDIA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
27. CHINA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
28. JAPAN ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
29. SOUTH KOREA ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF ASIA-PACIFIC ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF THE WORLD ANTIFUNGAL AGENT MARKET SIZE, 2021-2028 ($ MILLION)
